Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Tomas J. Philipson · SciRah

Researcher profile · Semantic Scholar

Tomas J. Philipson

Share profile

Tomas J. Philipson — researcher profile on SciRah

h-index: 30
Works: 138
Citations: 3,726

Most-cited papers

The Growth of Obesity and Technological Change
D. Lakdawalla, Tomas J. Philipson
2009Economics and Human Biology379 citations Open access
Semantic Scholar
The nonprofit sector and industry performance
D. Lakdawalla, Tomas J. Philipson
2006197 citations
Semantic Scholar
How cancer patients value hope and the implications for cost-effectiveness assessments of high-cost cancer therapies.
D. Lakdawalla, J. Romley, Y. Sanchez, J. R. Maclean +2 more
2012Health Affairs119 citations
Semantic Scholar
RAND Corporation From the SelectedWorks of Darius N . Lakdawalla September , 2006 Welfare-Enhancing Technological Change and the Growth of Obesity
D. Lakdawalla, Tomas J. Philipson
2017115 citations
Semantic Scholar
Cost-effectiveness analysis and innovation.
A. Jena, Tomas J. Philipson
2008Journal of Health Economics109 citations
Semantic Scholar
The Development of Intermediate Clinical Endpoints in Cancer of the Prostate (ICECaP).
C. Sweeney, M. Nakabayashi, M. Regan, Wan-Ling Xie +10 more
2015Journal of the National Cancer Institute80 citations Open access
Semantic Scholar
An analysis of whether higher health care spending in the United States versus Europe is ‘worth it’ in the case of cancer
Tomas J. Philipson, Michael R. Eber, D. Lakdawalla, M. Corral +2 more
2012Health Affairs73 citations Open access
Semantic Scholar
Geographic Variation in Health Care: The Role of Private Markets
Tomas J. Philipson, S. Seabury, Lee M. Lockwood, D. Goldman +1 more
201060 citations Open access
Semantic Scholar
The value of life near its end and terminal care by
Tomas J. Philipson, Gary Becker, Dana P. Goldman, Kevin Murphy
200960 citations
Semantic Scholar
The large social value resulting from use of statins warrants steps to improve adherence and broaden treatment.
D. Grabowski, D. Lakdawalla, D. Goldman, Michael R. Eber +5 more
2012Health Affairs56 citations
Semantic Scholar
Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA.
D. Goldman, D. Lakdawalla, Tomas J. Philipson, Wesley Yin
2010Health Economics47 citations
Semantic Scholar
Cost-effectiveness as a price control.
A. Jena, Tomas J. Philipson
2007Health Affairs46 citations
Semantic Scholar
Clinical and economic outcomes of nutrition interventions across the continuum of care
M. D. V. de van der Schueren, M. Elia, L. Gramlich, Michael P. Johnson +4 more
2014Annals of the New York Academy of Sciences41 citations Open access
Semantic Scholar
Endogenous Cost-Effectiveness Analysis in Health Care Technology Adoption
A. Jena, Tomas J. Philipson
200941 citations Open access
Semantic Scholar
Quality-Adjusted Cost Of Care: A Meaningful Way To Measure Growth In Innovation Cost Versus The Value Of Health Gains
D. Lakdawalla, J. Shafrin, Claudio Lucarelli, S. Nicholson +2 more
2015Health Affairs36 citations Open access
Semantic Scholar
Cost-benefit analysis of the FDA: The case of the prescription drug user fee acts
Tomas J. Philipson, E. Berndt, Adrian H. B. Gottschalk, Eric C. Sun
200835 citations Open access
Semantic Scholar
‘Me-Too’ Innovation in Pharmaceutical Markets
A. Jena, J. Calfee, E. Mansley, Tomas J. Philipson
2009Forum for Health Economics & Policy34 citations Open access
Semantic Scholar
The impact of comparative effectiveness research on health and health care spending,
Anirban Basu, A. Jena, Tomas J. Philipson
2011Journal of Health Economics32 citations Open access
Semantic Scholar
Does Intellectual Property Restrict Output? An Analysis of Pharmaceutical Markets
D. Lakdawalla, Tomas J. Philipson
2012Journal law and economy31 citations Open access
Semantic Scholar
The aggregate value of cancer screenings in the United States: full potential value and value considering adherence
Tomas J. Philipson, T. Durie, Z. Cong, A. M. Fendrick
2023BMC Health Services Research30 citations Open access
Semantic Scholar
The Benefits From Giving Makers Of Conventional `Small Molecule' Drugs Longer Exclusivity Over Clinical Trial Data
D. Goldman, D. Lakdawalla, J. Malkin, J. Romley +1 more
2011Health Affairs29 citations Open access
Semantic Scholar
Economic Burden of Disease-Associated Malnutrition in China
M. Linthicum, Julia Thornton Snider, R. Vaithianathan, Yanyu Wu +4 more
2015Asia-Pacific journal of public health26 citations
Semantic Scholar
Cancer mortality reductions were greatest among countries where cancer care spending rose the most, 1995-2007.
Warren Stevens, Tomas J. Philipson, Z. Khan, J. MacEwan +2 more
2015Health Affairs26 citations
Semantic Scholar
Pharmacy cost sharing, antiplatelet therapy utilization, and health outcomes for patients with acute coronary syndrome.
Tomas J. Philipson, E. Mozaffari, J. R. Maclean
2010American Journal of Managed Care26 citations
Semantic Scholar
Government perspective: food labeling.
Tomas J. Philipson
2005American Journal of Clinical Nutrition26 citations Open access
Semantic Scholar
HETEROGENEITY IN ACTION: THE ROLE OF PASSIVE PERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH
A. Basu, A. Jena, D. Goldman, Tomas J. Philipson +1 more
2013Health Economics25 citations Open access
Semantic Scholar
Surplus Appropriation from R&D and Health Care Technology Assessment Procedures by
Tomas J. Philipson
200625 citations
Semantic Scholar
The Contributions of Improved Therapy and Earlier Detection to Cancer Survival Gains, 1988-2000
Eric C. Sun, A. Jena, D. Lakdawalla, C. Reyes +2 more
201024 citations
Semantic Scholar
Understanding and Overcoming Barriers to Medication Adherence: A Review of Research Priorities
S. Seabury, Charu N. Gupta, Tomas J. Philipson, L. Henkhaus
2014Journal of Managed Care & Specialty Pharmacy23 citations Open access
Semantic Scholar
Drug licenses: a new model for pharmaceutical pricing.
D. Goldman, A. Jena, Tomas J. Philipson, Eric C. Sun
2008Health Affairs23 citations Open access
Semantic Scholar
Assessing the Safety and Efficacy of the FDA: The Case of the Prescription Drug User Fee Acts
Tomas J. Philipson, Ernst R. Berndt, Adrian H. B. Gottschalk, Matthew W. Strobeck
200523 citations Open access
Semantic Scholar
The option value of innovative treatments in the context of chronic myeloid leukemia.
Y. Sanchez, J. Penrod, Xiaoli Qiu, J. Romley +2 more
2012American Journal of Managed Care21 citations
Semantic Scholar
The Value of Diagnostic Testing in Personalized Medicine
D. Goldman, Charu N. Gupta, E. Vasudeva, K. Trakas +6 more
2013Forum for Health Economics & Policy20 citations
Semantic Scholar
Association Between Breast Cancer Disease Progression and Workplace Productivity in the United States
Wes Yin, R. Horblyuk, J. Perkins, S. Sison +4 more
2017Journal of Occupational and Environmental Medicine18 citations
Semantic Scholar
External Costs of Risky Health Behaviors Associated with Leading Actual Causes of Death in the U.S.: A Review of the Evidence and Implications for Future Research
A. Zohrabian, Tomas J. Philipson
2010International Journal of Environmental Research and Public Health17 citations Open access
Semantic Scholar
Economics of Obesity
P. Huckfeldt, D. Lakdawalla, Tomas J. Philipson
200617 citations
Semantic Scholar
Can Oral Nutritional Supplements Improve Medicare Patient Outcomes in the Hospital?
D. Lakdawalla, J. Snider, D. Perlroth, C. LaVallee +4 more
2014Forum for Health Economics & Policy15 citations
Semantic Scholar
The Option Value of Innovation
Julia Thornton Snider, J. Romley, William B. Vogt, Tomas J. Philipson
2012Forum for Health Economics & Policy15 citations
Semantic Scholar
How Does Technological Change Affect Quality-Adjusted Prices in Health Care? Systematic Evidence from Thousands of Innovations
Kristopher J. Hult, Sonia Jaffe, Tomas J. Philipson
2017American Journal of Health Economics14 citations Open access
Semantic Scholar
The determinants of recent gains in cancer survival: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database
Eric C. Sun, D. Lakdawalla, C. Reyes, D. Goldman +2 more
200814 citations
Semantic Scholar
Tutorial on health economics and outcomes research in nutrition.
Tomas J. Philipson, M. Linthicum, J. Snider
2014JPEN - Journal of Parenteral and Enteral Nutrition13 citations
Semantic Scholar
Dynamic cost-effectiveness of oncology drugs.
Lu Yang, J. Penrod, N. Sood, S. Woodby +1 more
2012American Journal of Managed Care13 citations
Semantic Scholar
Utilization effects of Rx-OTC switches and implications for future switches
Christopher Stomberg, Tomas J. Philipson, Margaret Albaugh, N. Sood
201312 citations Open access
Semantic Scholar
NBER WORKING PAPER SERIES CAN MEDICAL PROGRESS BE SUSTAINED? IMPLICATIONS OF THE LINK BETWEEN DEVELOPMENT AND OUTPUT MARKETS
Anup Malani, Tomas J. Philipson
201111 citations
Semantic Scholar
NBER WORKING PAPER SERIES ENDOGENOUS COST-EFFECTIVENESS ANALYSIS IN HEALTH CARE TECHNOLOGY ADOPTION
A. Jena, Tomas J. Philipson
200911 citations
Semantic Scholar
Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection
S. Seabury, D. Goldman, Charu N. Gupta, Z. Khan +3 more
2016Forum for Health Economics & Policy10 citations
Semantic Scholar
The wider public health value of HCV treatment accrued by liver transplant recipients.
A. Jena, Warren Stevens, Y. S. Gonzalez, S. Marx +3 more
2016American Journal of Managed Care9 citations
Semantic Scholar
WORKING PAPER SERIES INTELLECTUAL PROPERTY AND MARKETING
Darius N. Lakdawalla, Tomas J. Philipson, Y. Wang
20069 citations
Semantic Scholar
Five myths about cancer care in America.
D. Goldman, Tomas J. Philipson
2014Health Affairs8 citations
Semantic Scholar
Innovation and Technology Adoption in Health Care Markets
A. Jena, Tomas J. Philipson
20088 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Lakdawalla×19
Invite
D. Lakdawalla — researcher profile on SciRah
D. Goldman×13
Invite
D. Goldman — researcher profile on SciRah
A. Jena×12
Invite
A. Jena — researcher profile on SciRah
J. Romley×4
Invite
J. Romley — researcher profile on SciRah

×4

Invite

Eric C. Sun — researcher profile on SciRah

M. Linthicum×4

Invite

M. Linthicum — researcher profile on SciRah

Invite

J. Penrod — researcher profile on SciRah

Invite

S. Seabury — researcher profile on SciRah

Invite

Z. Khan — researcher profile on SciRah

Julia Thornton Snider×3

Invite

Julia Thornton Snider — researcher profile on SciRah

Charu N. Gupta×3

Invite

Charu N. Gupta — researcher profile on SciRah

Invite

N. Sood — researcher profile on SciRah